Sorry, you need to enable JavaScript to visit this website.

This site is intended only for healthcare professionals resident in the United Kingdom

Treatment pathways and management of haemato-oncology patients with invasive fungal infections (IFIs)

This promotional meeting is organised and funded by Pfizer and may include reference to Pfizer medicines relevant to agenda topics.

  • Fungal Topic

Treatment pathways and management of haemato-oncology patients with invasive fungal infections (IFIs)

Date: 6th October & 8th October

Time: 12pm - 6th October 
            6pm - 8th October 

Duration: 1 hour

Additional details: This is a live webinar. A live Q&A with Dr Nabeela Mughal will be available. 

Register Here

About the webinar

 This webinar is a promotional meeting that will focus on:
•    The current diagnostic landscape and considerations in haemato-oncology patients
•    The treatment options and the role of antifungal stewardship in optimising treatment outcomes for invasive fungal infections in this patient cohort
•    The various touchpoints along the patient journey in haemato-oncology patients
•    How the current environment has impacted existing pathways and management of these patients

About the speaker

Dr Nabeela Mughal
Infectious Diseases and Microbiology Consultant,
Chelsea and Westminster Hospital NHS Trust

This meeting is organised & funded by Pfizer Ltd. Please note that, under the law and the ABPI Code of Practice, Pfizer may only promote its medicines and provide hospitality to members of the healthcare professions and other relevant decision makers. Therefore, no unqualified person (e.g. medical students, non-medical spouses/partners/family members) may be invited to or attend Pfizer promotional meetings.